Evidence map›Paper›PMID 42682333›Full record

ArticleOpen veterinary journal2026

Chitosan nanoparticles as a sustainable antibacterial approach for inhibiting

Mahmoud Abd El-Mongy, Manar M Farouk, Nadia Saed Arafa, Amani Abd El Latif Mosleh, Shaimaa Moawad Nada

Abstract read
In one paragraph

Article in Open veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahmoud Abd El-MongyDepartment of Microbial Biotechnology, Faculty of Genetic Engineering and Biotechnology Research, University of Sadat City, Sadat City, Egypt.
Manar M FaroukDepartment of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Nadia Saed ArafaAnimal Health Research Institute, Shibin El-Kom Branch, ARC, El-Menufia, Egypt.
Amani Abd El Latif MoslehAnimal Health Research Institute, Shibin El-Kom Branch, ARC, El-Menufia, Egypt.
Shaimaa Moawad NadaAnimal Health Research Institute, Shibin El-Kom Branch, ARC, El-Menufia, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mastitis poses a significant economic impact in the dairy sector and serves as a potential source of infection for healthy cows, impeding attempts to become self-sufficient in milk production. Treatment failure due to the development of multidrug-resistant pathogens raises concern about the need to investigate antimicrobial alternatives. Nanoparticles are attracting attention as a therapeutic approach for various infectious disorders. Despite the importance of this issue, limited research has been conducted on resistant bacteria that cause mastitis. Aim: This study aimed to investigate the occurrence and antimicrobial susceptibility profile of Methods: A total of 100 milk samples were collected from dairy cattle and buffaloes with clinical and subclinical mastitis using a convenience sampling approach, with no randomization. As such, the sample may not fully represent all dairy sources in the study area. Mastitis was initially detected using the California mastitis test. Following standard biochemical tests and bacteriological culture, suspected positive samples were molecularly identified using polymerase chain reaction and phylogenetic analysis of 1 Results: Results revealed that Conclusion: The outcomes of this study collectively provide a crucial starting point for developing a novel treatment plan for bovine mastitis.

Indexed as

Anti-Bacterial AgentsChitosanEscherichia coliEscherichia coli InfectionsMastitis, BovineNanoparticlesSalmonellaSalmonella Infections, AnimalAnimalsBuffaloesCattleFemaleMicrobial Sensitivity TestsMilkAnti-Bacterial AgentsChitosanAntimicrobial resistanceBovine mastitisE. coliNanoparticlesSalmonella

Identifiers

PMID42682333
PMCPMC13317543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.